Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results from Spectral's Tigris Trial
[email protected]
Mon, 06/01/2026 - 10:03
TORONTO, Canada and DEERFIELD, Ill., USA – June 4, 2026 – Spectral Medical Inc. (“Spectral”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...